UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042889
Receipt number R000048954
Scientific Title Factual survey of motor vehicle driving by patients with visual field defects
Date of disclosure of the study information 2021/01/04
Last modified on 2021/01/03 15:05:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Factual survey of motor vehicle driving by patients with visual field defects

Acronym

Factual survey of motor vehicle driving by patients with visual field defects

Scientific Title

Factual survey of motor vehicle driving by patients with visual field defects

Scientific Title:Acronym

Factual survey of motor vehicle driving by patients with visual field defects

Region

Japan


Condition

Condition

Glaucoma, Retinal disease, Optic nerve disease, Visual pathway disease

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Factual survey of driving performance for patients with visual field defects

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To investigate the relationship between age, disease, severity of visual field defect, questionnaire, and motor vehicle accidents in visual field defects patients

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1)Written informed consent: Patients capable of providing written consent by themselves after full explanation of the study details using written information to patients.
2) Patients aged 20 to 80 years old
3) Males and females.
4) Visual field defect by ocular disease
5) Holder of driver's license

Key exclusion criteria

1) History of mental disorder
2) History of strabismus
3) Unable to perform visual field test
4) Patients whom doctor judged to be ineligible for this study.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Kazuhisa
Middle name
Last name Sugiyama

Organization

Kanazawa University

Division name

Ophthalmology

Zip code

9208641

Address

13-1 Takara-machi, Kanazawa , Ishikawa, Japan

TEL

076-265-2403

Email

ksugi@med.kanazawa-u.ac.jp


Public contact

Name of contact person

1st name Sachiko
Middle name
Last name Udagawa

Organization

Kanazawa University Hospital

Division name

Ophthalmology

Zip code

9208641

Address

13-1 Takara machi, Kanazawa , Ishikawa, Japan

TEL

0762652000

Homepage URL


Email

s-uda@med.kanazawa-u.ac.jp


Sponsor or person

Institute

Japan imaging and perimetry society

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Department of Ophthalmology, Kanazawa University Graduate School of Medical Science
Tajimi Iwase eye clinic

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical ethics committee of Kanazawa university

Address

13-1 Takara machi, Kanazawa , Ishikawa, Japan

Tel

076-265-2103

Email

t-isomu@adm.kanazawa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

たじみ岩瀬眼科 (岐阜県)
すずむら眼科 (東京都)
おおくぼ眼科クリニック (石川県)
新潟大学眼科 (新潟県)
三重大学眼科 (三重県)
西葛西・井上病院 (東京都)
東京慈恵会医科大学眼科 (東京都)
慶応義塾大学眼科 (東京都)
北里大学眼科(神奈川県)
埼玉医科大学眼科 (埼玉県)


Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 12 Month 31 Day

Date of IRB

2020 Year 01 Month 22 Day

Anticipated trial start date

2020 Year 02 Month 01 Day

Last follow-up date

2021 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2021 Year 01 Month 03 Day

Last modified on

2021 Year 01 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048954


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name